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Available online at www.sciencedirect.comAn imbalance of the normal microbial flora, breakage of epithelial
barriers or dysfunction of the immune system favour the
transition of the human pathogenic yeast Candida albicans from
a commensal to a pathogen. C. albicans has evolved to be
adapted as a commensal on mucosal surfaces. As a commensal
it has also acquired attributes, which are necessary to avoid or
overcome the host defence mechanisms. The human host has
also co-evolved to recognize and eliminate potential fungal
invaders. Many of the fungal genes that have been the focus of
this co-evolutionary process encode cell wall components. In
this review, we will discuss the transition from commensalism to
pathogenesis, the key players of the fungal cell surface that are
important for this transition, the role of the morphology and the
mechanisms of host recognition and response.
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Introduction
The yeast Candida albicans is by far the most common
human pathogenic Candida species and can cause a broad
spectrum of diseases including skin, mucosal and
systemic infections (candidiasis) [1]. C. albicans infections
of mucosal surfaces are extremely common and occur in
otherwise healthy individuals. However, Candida species
can cause life threatening infections in immunocompro-
mised individuals or when natural barriers are damaged.
During these infections, the fungus is able to colonize and
multiply within almost all organs of the human body.
Under normal circumstances, C. albicans is a mucosal
commensal, predominantly in the gastrointestinal tract,
Open access under CC BY license.Current Opinion in Microbiology 2012, 15:406–412 of the majority of the human population. Here, the fungus
is controlled by: (1) the normal microbial flora, (2) epi-
thelial barriers and (3) the innate immune system. This is
reflected by the fact that antibiotic treatments, or surgery,
polytrauma and catheters and neutropenia are all con-
sidered as major risk factors for invasive candidiasis.
Human polymorphisms that affect mucosal recognition
mechanisms have also been recognized as underlying a
range of superficial forms of candidiasis in specific patient
groups [2]. Although the commensal stage is frequently
described as ‘harmless’ to the host, it is likely that this
stage is highly regulated and the fungus is continuously or
transiently interacting with the host immune system [3].
Therefore, it may be that the adaptation to warm-blooded
animals includes not only an adaptation to a life on
mucosal surfaces, but also selection of attributes, which
are necessary to avoid or overcome the defence mechan-
isms of the host (discussed as ‘The commensal school’ in
[4]). It is also likely that the human host has evolved to
recognize and deal with a potential fungal invader so that
the evolved state is one of commensalism. Many of the
genes that have been the focus of this co-evolution
encode cell wall components and concomitantly, the
morphology, of the fungus. The way in which these
components orchestrate the ecology of the fungus in
the human host is the subject of this review.
Fungal mechanisms associated with
commensalism and pathogenicity
It is not known whether commensal proliferation of C.
albicans on mucosal surfaces occurs mostly within the
mucous layer, like other members of the microbial flora,
or whether fungal cells are in physical contact with
epithelial cells. During pathogenesis, three different
and dynamic stages can be discriminated: (i) adhesion,
(ii) invasion, and (iii) damage [5,6,7]. During these
processes, inflammation – a characteristic of fungal dis-
ease – is initiated. However, it remains to be elucidated
which of these stages are truly characteristic for patho-
genesis and can be taken as representing the transition
from a commensal to a parasitic interaction with the host.
Adhesion to other fungal or bacterial or host cells is
required for both commensalism and pathogenesis. In
Candida species, adhesion is mediated by some well
characterized adhesion factors such as members of the
Als family, Hwp1, Eap1, and others [8]. Several of these
are glycosylphosphatidylinositol (GPI)-proteins (linked
to cell wall glucan, see below) or GPI-anchored proteins
(linked to the cell membrane), which are exposed at thewww.sciencedirect.com
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Invasive properties of hyphae of C. albicans. (A) Invasion of a model
epithelium from the chick chorioallantoic membrane by hyphae of C.
albicans (Gow N.A.R., with permission), (B) the ramification of hyphae
from a human lung lesion, (C) invasion into murine liver after
intraperitoneal infection. Note the almost parallel invasion potentially
indicating communication between hyphae (from Das A. (B) and
Jacobsen I.D. (C), with permission).cell surface. Adhesins such as Als3 and Hwp1 are pre-
dominantly expressed during hypha formation making
this morphology particularly adherent. Dysfunction in
cell wall regulation may cause inappropriate exposure
or aberrant surface localization of adhesins and thus
can reduce adhesion properties [7,9].
Invasion of C. albicans into non-professional phagocytic
cells is hypha-dependent and can occur via two different
routes: induced endocytosis or active penetration.
Induced endocytosis is a host-driven activity by which
hypha-associated invasins, in particular Als3, bind to a
host receptor on epithelial or endothelial cells (E-cad-
herin, N-cadherin) to trigger fungal up-take [10]. Active
penetration, either directly into host cells or between host
cells, requires fungal turgor, normal vacuole formation,
cell wall integrity, hyphal extension and other physical
forces [7,11]. Fungal cells can sense the topography of
the host surface and respond by thigmotropic orientation
[12]. They may also communicate with other fungal cells
by quorum sensing mechanisms [13]. Quorum sensing not
only regulates morphology (yeast or hypha growth), but
may also orchestrate deep invasion into tissues since
histological analyses frequently show almost synchro-
nized parallel invasion of hyphae (Figure 1).
Although it seems obvious that invasion is a truly pathogenic
stage, it may be that C. albicans moderately invades epithelial
cells even in the commensal phase in order to maintain a
foothold on proliferating epithelia and to avoid being
sloughed off from epithelial surfaces. This would explain
immunological data indicating continuous interactions exist
between C. albicans and the host [3,14]. Furthermore, inva-
sion via induced endocytosis does not inevitably cause
damage since killed fungal hyphae with no potential to
cause disease can be taken up via this mechanism [7,15].
By contrast, induction of host damage is a key characteristic
of pathogenesis. Damage directly caused by the fungus
occurs when hyphae invade deep into or through host cells
(interepithelial invasion) and is potentiated by virulence
factors such as the secretion of hydrolases, unknown dama-
ging factors and some attributes which are also character-
istic for active penetration, for example hyphal extension
[7,11]. However, tissue damage and disease occurs not
only by direct fungal activities, but may also be the result of
an overactivation of the immune system, for example
massive infiltration of neutrophils or, finally, an inappropri-
ate and unbalanced systemic response causing life threa-
tening sepsis. Thus, immune recognition may not only be
beneficial and crucial for fighting invading fungi, but may
also be an integral part of the disease process.
Immune recognition and cell wall structure
The C. albicans cell wall is 90% carbohydrate and 10%
protein. As a generalization, the carbohydrates dominate
immune recognition and the proteins have the key role inwww.sciencedirect.com adhesive interactions with cell host surfaces. However,
cell wall proteins are relevant as antigens and therefore
vaccine targets, for example Als3 [16], and it is known that
cell wall associated or secreted proteins such as the
aspartic proteases are recognized by immune cells [17].Current Opinion in Microbiology 2012, 15:406–412
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Transmission electron micrograph showing a section of the C. albicans cell wall and a cartoon showing the arrangement of the major components and
(on the rhs) the role of those components in immune activation and suppression. TEM by Walker L., adapted from [35] with permission.The polysaccharides are in three major forms: (i) mannans
(O-linked and N-linked), which are post-translational
modifications of the cell wall proteins; (ii) b-glucans
(which comprise two types b-1,3 glucan and b-1,6 glu-
can); and (iii) chitin and/or its deacetylated form chitosan.
The mannoproteins form a fibrillar outer layer, while the
b-glucan/chitin layer lies under the mannoprotein outer
layer (Figure 2). It has also been suggested recently that
some of the mannan is free in the cell wall [18].
The cell wall proteins are mostly attached via GPI-rem-
nants to b-1,3 glucan via b-1,6 glucan, which acts as a linker
molecule (or anchored via GPI with the membrane, as
discussed above). Chitin and b-1,3 glucan are structural
polysaccharides in the inner cell wall layer. Both of these
molecules convey strength and shape to the cell wall. By
contrast, the mannans of the outer cell wall are less struc-
tured, but have low permeability and porosity. Therefore,
the mannan layer affects the resistance of the wall to attack
by host molecules and the permeability of the wall to
antifungal drugs, but does not influence cell shape.
All of the polysaccharides of the cell wall contribute to the
immunological signature of C. albicans [19]. O-linked and
N-linked mannans are pathogen associated molecular
patterns (PAMPS) that engage a wide range of Toll like
receptor (TLR) and C-type lectin Pattern Recognition
Receptors (PRRs) [20]. In myeloid cells O-linked man-
nans are recognized by TLR4, whilst N-mannan is recog-
nized by the Mannose Receptor Protein (MRP),
Galectin-3, as well as Mincle and DC-SIGN. Mannans
include both a-linked and b-linked sugars. It is clear that
the C-type lectin Galectin-3 has an affinity for b-mannose
in the form of b-1,2, oligomannosides whilst most of the
other receptors are presumed to bind predominantly a-
linked mannose oligosaccharides [19]. The major PRR for
b-1,3 glucan is the C-type lectin Dectin-1 [21] which canCurrent Opinion in Microbiology 2012, 15:406–412 collaborate with TLR2, perhaps by forming a co-receptor
complex, which together amplify recognition responses
triggered by the Syk kinase and TLR/MyD88 dependent
pathways [22]. Dectin-1-b-glucan interactions are also
critical for the activation of inflammasome complexes
[23,24]. Phospholipomannan in the wall is recognized
by Galectin-3, which may be coupled to TLR2 and is
likely to be of special importance in recognizing C.
albicans in the gut mucosa. b-1,6 Glucan, which acts as
a linker between the GPI-proteins of the wall and the b-
1,3 glucan skeletal polysaccharide, is an opsonic receptor
of neutrophils [25]. b-1,3 Glucan is a major pro-inflam-
matory mediator and conditions that enhance its exposure
at the surface of the cell increase the amount of pro-
inflammatory cytokines that are induced. The overlying
mannan layer is not strictly an ‘immunological shield’
since it too is recognized by a plethora of PRRs (see
above), but it is true that damage to the integrity of the
mannan layer with consequential exposure of more b-1,3
glucan at the cell surface enhances the strength of the pro-
inflammatory signal. This enhanced b-1,3 glucan-
exposure can occur after exposure to echinocandins
and during the progression of an infection as host
enzymes act on the fungal cell surface [26]. It should
be noted that most of these studies were done with
myeloid cells, such as macrophages. Recognition by epi-
thelial (or other cell types) have been much less well
studied and are likely to differ in many key respects.
Chitin and its deacetylated form chitosan also participate
in immune recognition, activation and attenuation
[27,28,29]. The C-type lectin RegIIIg (HIP/PAD) in
the neutrophil-like Paneth cells of the small intestine,
and FIBCD1, a calcium-dependent acetyl group-binding
tetrameric protein have been implicated as chitin-binding
receptors [30], however, the chitin binding receptor of
myeloid cells has yet to be identified. The role of chitin inwww.sciencedirect.com
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induces both pro-inflammatory and anti-inflammatory
responses and the type of response is very dependent
on the size of the chitin particle (see [27]; and summary
in [31]). A significant proportion of chitin is deacetylated
to chitosan in the walls of zygomycetes and other fungi
such as the basidiomycete yeast Cryptococcus neoformans. It
is likely that chitin and chitosan have separate immune
recognition mechanisms. For example, chitosan, but not
its acetylated form chitin, activates the NLRP3 inflam-
masome in a phagocytosis-dependent manner [32] and
dendritic cells can be activated by chitosan, and not chitin
via a mechanism that involves TLR4 [33]. The next few
years are likely to lead to further discoveries of the
cognate receptors for both chitin and chitosan by cells
that participate in the primary innate immune response.
Recognition during morphogenesis,
commensalism and pathogenesis
One of the key characteristics and predominant virulence
attributes of C. albicans is the ability to switch between
yeast and hyphal growth [34]. These morphological forms
differ in growth dynamics, cellular structure, gene expres-
sion pattern, cell surface molecules, dissemination and
invasion potential [35]. Some of the hypha-associated
factors are clearly linked with virulence potential, for
example Hwp1 (adhesion) [36], Als3 (adhesion, invasion,
iron aquisition) [15,37,38], Sod5 (detoxification of reac-
tive oxygen species) [39–41], or Sap4-6 (proteases
involved in several aspects of interaction with the host)
[42]. It is clear that yeast and hyphae are differentially
recognized by immune cells [43] and that the cytokine
signature induced by yeast and hyphal cells differs sig-
nificantly. Hyphae induce low levels of IL-12 and IFNg
from DCs but higher levels of IL-4, and hyphae are not
recognized by TLR4 [44].
Because hyphae do not form bud scars, which have sur-
face-exposed b-1,3 glucan, they also do not induce a
strong Dectin-1 mediated pro-inflammatory response
[45]. Dectin-2 mediated recognition of mannans from
hyphae and yeast cells has also been suggested to differ
[46]. The mannans of yeast and hyphae differ physically
and chemically (e.g. [23]) and this may contribute to the
differential immune reactivity of these two morphological
forms together with morphology associated proteins
[47,48]. For example, surface-associated pH-regulated
antigen 1 protein (Pra1), a predominantly hypha-associ-
ated protein, plays a pivotal role in the recognition of C.
albicans by human neutrophils and enhances neutrophil
antimicrobial responses. However, the fungus can coun-
teract some of these defence mechanisms by releasing
soluble Pra1 [49]. Recognition of Pra1p occurs via the
leucocyte receptor integrin a(M)b2 and complement re-
ceptor 3 [49,50]. Furthermore, Pra1 can bind human
complement inhibitors and thus may mediate fungal
complement evasion [51].www.sciencedirect.com Recently, mechanisms have emerged that enable an un-
derstanding of how colonizing (yeast cells) and invasive
(hyphal) forms of C. albicans are discriminated by epi-
thelial cells and the underlying mucosa. It was shown that
fungal burden and the transition from yeast to hypha have
a profound influence on immune activation of epithelial
cells [52]. Initial immune recognition of C. albicans was
found to be cell wall dependent, but morphology-inde-
pendent, and involved activation of the NF-kB pathway
and the MAPK-mediated transcription factor c-Jun. How-
ever, this response appears to be transient and does not
result in epithelial cytokine induction. Full epithelial
activation with concomitant cytokine induction is only
induced when hyphal burdens increase, but not yeast
burdens, providing a mechanism that would facilitate
discrimination between the colonizing and invading
forms of the fungus. Recognition of increased hyphal
burdens occurs in both oral and vaginal epithelial cells
and results in the activation of two key proteins: the
transcription factor c-Fos, which is activated by the p38
pathway, and the MAPK phosphatase MKP1, which is
activated via the MEK1/2–ERK1/2 pathway and
regulates the MAPK-mediated cytokine response. c-
Fos and MKP1 activation is contact dependent but inde-
pendent of viability and avidity of adherence. The hypha-
associated moieties that induce c-Fos and MKP1 acti-
vation are unknown, but cell wall polysaccharides (man-
nan, b-glucan, chitin) are unlikely to be the activating
factors as these only activate NF-kB and c-Jun [52,53].
For mucosal immunity, Th-17 cell subsets and their
associated cytokines, IL-17A, IL-17F and IL-22, play
key roles in discriminating colonization and invasive
disease [54,55]. Human Th-17 differentiation in memory
CD4 T cells is induced by IL-1b, IL-6 and TGFb1
cytokines (and maintained by IL-23) from antigen-pre-
senting cells. While yeast cells and hyphae both induce
IL-23 and IL-6, only hyphae induce IL-1b in macro-
phages. In addition, alterations in tryptophan metabolism
by C. albicans hyphae can also down regulate the Th-17
response [56]. The hypha-specific induction of IL-1b is
mediated by the NLRP3 inflammasome and C. albicans
yeast-locked mutants do not activate the inflammasome
and therefore do not induce IL-1b secretion by macro-
phages. In myeloid cells, activation of IL-1b requires the
pro-form of the cytokine to be processed by the caspase-1
protease that is activated via the Dectin-1 pathway.
Whilst both yeast cells and hyphae induce pro IL-1b
mRNA and protein, only hyphae induce caspase-1 and
hence secretion of active IL-1b and subsequent IL-17
secretion by Th-17 cells leading to recruitment of neu-
trophils (Figure 3) [23,35]. Recently the NLRC4
inflammasome has also been shown to be protective for
mucosal immunity to C. albicans [57]. Overall, this
suggests that the transition from colonizing yeast cells
to tissue-invading hyphae signals the activation of a
protective Th-17 response in the mucosa. IL-22 pro-Current Opinion in Microbiology 2012, 15:406–412
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Two host danger response pathways that indicate the shift from C. albicans commensal growth to infection. (A) Monocytes recognize both yeast and
hyphal cells which both induce caspase-1 formation that processes pro-IL-1b to the mature form of IL-1b. This induces T cell differentiation to Th17
cells, while with macrophages only hyphae induce pro-IL-1b processing by caspase-1. Consequently, in the mucosa, yeast cells do not induce a
strong pro-inflammatory response, but invasive hyphal cells induce protective Th-17 immunity [35]. (B) Oral epithelial cells are able to discriminate
between yeast and hypha via a bi-phasic MAPK response. Low burden of colonising yeasts cells are recognized by an unknown PRR causing
activation of NF-kB and weak, early and transient activation of a first MAPK response and c-Jun. In a second phase, high burden of hyphae are
recognized which results in continued activation of NF-kB along with further, stronger activation of a secondary MAPK response and activation of c-
Fos, which causes cytokine expression. The MKP1 phosphatase acts in a negative feedback loop and prevents an over-reaction of the immune
system [52].duction is presumed to augment this protective response
by inducing epithelial cells to produce defensins. It may
be that epithelial damage caused by penetrating hyphae
also leads to the release of cellular ATP, which is known
to also drive Th-17 cell differentiation. Therefore,
hyphae may have several roles in inducing immune
responses in: (a) specifically activating the p38/c-Fos
and ERK/MKP1 pathways leading to immune activation
and regulation; (b) enhancing the secretion of Th-17-type
cytokines; (c) causing damage and release of ATP that
activates the inflammasome of immune cells; and (d)
inducing IL-22 production by Th-17 cells that enhances
the production of defensins in the epithelium. The nature
of the morphology-specific PAMPs that drive these polar-
ization in immune response remain to be discovered.Current Opinion in Microbiology 2012, 15:406–412 Conclusions
The transition from C. albicans commensalism to invasive
growth is not an event, but rather a shift in dynamic
equilibrium between host and pathogen associated fac-
tors. For the fungus to be retained on the healthy surface
of a host tissue it must be able to counter the effects of the
sentinel activity of mucosal immunity mechanisms, to
compete with other microbes for space and nutrients, and
the sloughing off of the cellular substrate to which it is
tethered. To do this it must have evolved mechanisms for
retention and immune avoidance that in a different con-
text (e.g. immunosuppression) can be seen as traits that
also promote pathogenesis. Emerging evidence does,
however, support a view that yeast cells on the surface
of the mucosa do not trigger strong inflammatorywww.sciencedirect.com
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damage, activate inflammasome complexes and MAP
kinase pathways and induce the recruitment of neutro-
phils that operate to counter their further ramification at
the attempted site of infection. Many of these mechan-
isms of homeostasis and innate immune activation are
controlled or triggered by molecules of the fungal cell
wall. Cell wall proteins represent many of the key
pathogen virulence attributes (adhesins, invasins, hydro-
lases, etc.), but may also be recognized by the host. Cell
wall carbohydrates act predominantly as PAMPS that
induce both protective immunity and potentially patho-
genic overactivation of the inflammatory response. The
complexity of this interaction of the host is also expressed
at subsequent phases of infection, for example during
invasive growth. In all these dynamic processes the cell
wall plays a central role in defining the equilibrium
between commensalism and disease.
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